BioCanada

Found 19,745 articles

• And now, this

  6/20/2018

  There are no words to describe and acknowledge this historic moment in Canada.

• 

  September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...

  9/21/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

• Catching the Future of Life Sciences and the Opportunities for Canada

  9/21/2018

  In celebration of Global Biotech Week, CDRD and BIOTECanada invite you to a thought-provoking evening to experience changes in life sciences and biotechnology that are unfolding today.

• Ontario becomes first province to provide public funding of TRESIBA for adults with diabetes mellitus

  9/21/2018

  Novo Nordisk Canada Inc. announces that Ontario will now reimburse TRESIBA® (insulin degludec injection) FlexTouch® prefilled pen in both 100 units/mL and 200 units/mL doses, as a general benefit for people living with Type 2 and Type 1 diabetes.

• Canopy Growth Congratulates Canopy Rivers for its Listing on the TSX Venture Exchange

  9/20/2018

  Canopy Growth Corporation wishes to congratulate the entire team at Canopy Rivers Inc. as they take a leap forward and commence trading today on the TSX Venture Exchange as under the ticker symbol, "RIV".

• Correvio to Participate In Upcoming September and October 2018 Investor Conferences

  9/20/2018

  Correvio Pharma Corp. today announced that Correvio management will participate in the following upcoming investor conferences:

• Advisory - Health Canada warns consumers to not use health products containing the potentially dangerous chemical DNP

  9/20/2018

  Canadians should not buy or use health products that contain 2,4-dinitrophenol, more commonly known as DNP, because it is toxic and can cause death.

• Beleave Announces 867,000 Square Feet of New Indoor Growing Capacity in B.C.

  9/20/2018

  Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce that is has entered into a partnership with Kannavis Biotech Corp. ("Kannavis") to invest, build and operate 867,000 square feet of indoor growing space in British Columbia in preparation for the anticipated demand for cannabis in the Canadian and International marketplace.

• Canopy Growth Congratulates Canopy Rivers (TSXV:RIV) for its Listing on the TSX Venture Exchange

  9/20/2018

  Canopy Growth Corporation wishes to congratulate the entire team at Canopy Rivers Inc. as they take a leap forward and commence trading today on the TSX Venture Exchange as under the ticker symbol, "RIV".

• Opsens - New product for the diagnosis of coronary stenosis with the heart at rest

  9/20/2018

  Opsens plans to begin commercialization by the end of calendar year 2018.

• Organigram & Canopy Growth partner in Newfoundland and Labrador by signing supply agreement including distribution and retail services

  9/20/2018

  Deal secures Organigram's portfolio within Canopy Growth's retail stores & launches B2B sales platform

• Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference

  9/20/2018

  Both will be featured in several presentations at the Transcatheter Cardiovascular Therapeutics 2018 scientific symposium to take place September 21-25, 2018 in San Diego, California.

• Neptune to Present at Sidoti & Company Fall 2018 Conference

  9/20/2018

  Management will present at 9:45 a.m. EDT and be available to meet with investors attending the conference that day.

• Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

  9/20/2018

  Covalon Technologies Ltd. today announces that it has entered into a definitive agreement to acquire AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC.

• Integrated Cannabis Company, Inc. Signs Distribution Agreement with Empower Clinics, Inc.

  9/20/2018

  The companies have recently engaged with their marketing and distribution teams to streamline the logistics of rolling out new products in the Empower clinics.

• Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany

  9/19/2018

  Neovasc, Inc. announced today that a Neovasc Reducer™ (the "Reducer") has now been implanted in 100 patients in Germany. The Reducer is a wire mesh implanted into a vein in the heart which treats patients with refractory angina.

• Nuvo Pharmaceuticals Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

  9/19/2018

  Would result in significant expansion of revenue and adjusted EBITDA

• Zymeworks Names Anthony Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer

  9/19/2018

  Zymeworks Inc. today announced it has named Anthony (Tony) Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer.

• Aralez Pharmaceuticals Enters Into Definitive "Stalking Horse" Purchase Agreements For Substantially All Assets

  9/19/2018

  Transactions valued at an aggregate of U.S. $240 million

• Aurinia to Participate in Upcoming Investor Conferences

  9/19/2018

  Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced its Chairman and CEO, Richard Glickman, will present a company overview at two upcoming investor conferences.